Interferon alpha-2a biosimilar - Profarma

Drug Profile

Interferon alpha-2a biosimilar - Profarma

Alternative Names: IFNa2a biosimilar - Profarma; PF-08 - Profarma

Latest Information Update: 30 Jun 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Profarma
  • Class Antineoplastics; Antivirals; Interferons
  • Mechanism of Action Interferon alpha stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Cancer; Viral infections

Most Recent Events

  • 17 Jun 2015 Early research in Cancer in Lithuania (Parenteral) (Profarma pipeline, June 2015)
  • 17 Jun 2015 Early research in Viral infections in Lithuania (Parenteral) (Profarma pipeline, June 2015)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top